The present study aims
to evaluate the beneficiary effect of Nigella sativa in radiotherapy or
chemotherapy. Cancer is one of the biggest threats of modern life, which is
accepted as the second cause of death after myocardial infarction. Current
chemotherapy, radiotherapy, surgery, etc. cannot provide complete treatment for
cancer cases that cannot be diagnosed early. Nigella sativa has been used in
the treatment of various diseases in traditional medicine for over 2000 years,
since it is a natural medicinal medicine as well as a spice in the kitchen. The
inadequacy of existing treatments encourages scientists to find alternative and
more effective treatment methods. Many studies have important effects such as
antibacterial, antifungal, antihelmintic, antioxidant, antidiabetic,
antiinflammatory, analgesic, gastroprotective, hepatoprotective,
renoprotective, anti-convulsant, antiastmia. As a result, Nigella sativa is
used in in-vivo and in-vitro studies in cancer treatment by utilizing its
beneficial and protective effects on many systems and it is known that it does
not harm healthy cells. Although scientific studies are conducted, the current
number of studies is limited. There is a need for clinical studies to show a
possible positive effect on the current types of cancer.
No comments:
Post a Comment